Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Allon Therapeutics Inc

+ Add to Watchlist

NPCUF:US

0.0001 USD 0.0001 100.00%

As of 20:10:01 ET on 02/24/2015.

Snapshot for Allon Therapeutics Inc (NPCUF)

Open: 0.0001 Day's Range: 0.0001 - 0.0001 Volume: 97,000
Previous Close: 0.0000 52wk Range: 0.0001 - 0.0005 1-Yr Rtn: -

Stock Chart for NPCUF

No chart data available.
  • NPCUF:US 0.0001
  • 1D
  • 1M
  • 1Y
0.0000
Interactive NPCUF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NPCUF

Current P/E Ratio (ttm) -
Estimated P/E(12/2013) -
Relative P/E vs. SPX -
Earnings Per Share (CAD) (ttm) -0.0600
Est. EPS (CAD) (12/2013) -
Est. PEG Ratio -
Market Cap (M USD) 0.01
Shares Outstanding (M) 141.10
30 Day Average Volume 9,417
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NPCUF

No data available

Company Profile & Key Executives for NPCUF

Allon Therapeutics Inc. is a drug discovery and development company focused on diseases and conditions of the central nervous system. The Company is developing novel neuroprotective central nervous system therapeutics with lead indications of Alzheimer's Disease and cognitive impairment.

Alistair StewartVP:Commercial Research
More Company Profile & Key Executives for NPCUF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil